APA

Bally C., Adès L., Renneville A., Sebert M., Eclache V., Preudhomme C., Mozziconacci M., de The H., Lehmann-Che J. & Fenaux P. (20140801). Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine. : Leukemia research.

Chicago

Bally Cecile, Adès Lionel, Renneville Aline, Sebert Marie, Eclache Virginie, Preudhomme Claude, Mozziconacci Marie-Joelle, de The Hugues, Lehmann-Che Jacqueline and Fenaux Pierre. 20140801. Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine. : Leukemia research.

Harvard

Bally C., Adès L., Renneville A., Sebert M., Eclache V., Preudhomme C., Mozziconacci M., de The H., Lehmann-Che J. and Fenaux P. (20140801). Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine. : Leukemia research.

MLA

Bally Cecile, Adès Lionel, Renneville Aline, Sebert Marie, Eclache Virginie, Preudhomme Claude, Mozziconacci Marie-Joelle, de The Hugues, Lehmann-Che Jacqueline and Fenaux Pierre. Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine. : Leukemia research. 20140801.